Showing results (11-20 of 168) with videos related to
Sort By:
Pageof 17
Drug Discovery Today|March 8, 2005
Mammalian carboxylesterases: from drug targets to protein therapeuticsMatthew R Redinbo, Philip M PotterCurrent Opinion in Chemical Biology|May 18, 2013
The human microbiome is a source of therapeutic drug targetsBret D Wallace, Matthew R RedinboDrug Metabolism Reviews|December 6, 2012
Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspectiveBret D Wallace, Matthew R RedinboToxins|September 16, 2020
Gut-Derived Protein-Bound Uremic ToxinsAmanda L Graboski, Matthew R RedinboCurrent Opinion in Structural Biology|November 3, 2005
Orphan nuclear receptors adopted by crystallographyHolly A Ingraham, Matthew R RedinboActa Crystallographica. Section F, Structural Biology Communications|May 3, 2018
Crystal structure of the mouse innate immunity factor bacterial permeability-increasing family member A1Michael S Little, Matthew R RedinboRSC Chemical Biology|June 19, 2025
Emerging gut microbial glycoside hydrolase inhibitorsMark E Kowalewski, Matthew R RedinboMolecular Omics|September 28, 2022
Multi-omic analysis of host-microbial interactions central to the gut-brain axisJoshua B Simpson, Matthew R RedinboCurrent Drug Metabolism|August 17, 2005
Structure and function of the human nuclear xenobiotic receptor PXRVirginia E Carnahan, Matthew R RedinboCancer Prevention Research (Philadelphia, Pa.)|July 3, 2020
The Gut Microbiota Impact Cancer Etiology through "Phase IV Metabolism" of Xenobiotics and EndobioticsSamantha M Ervin, Matthew R RedinboPageof 17